These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19087826)

  • 21. A D1 receptor antagonist, ecopipam, for treatment of tics in Tourette syndrome.
    Gilbert DL; Budman CL; Singer HS; Kurlan R; Chipkin RE
    Clin Neuropharmacol; 2014; 37(1):26-30. PubMed ID: 24434529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Centromedian-Parafascicular Complex Deep Brain Stimulation for Tourette Syndrome: A Retrospective Study.
    Testini P; Zhao CZ; Stead M; Duffy PS; Klassen BT; Lee KH
    Mayo Clin Proc; 2016 Feb; 91(2):218-25. PubMed ID: 26848003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.
    Müller-Vahl KR; Schneider U; Koblenz A; Jöbges M; Kolbe H; Daldrup T; Emrich HM
    Pharmacopsychiatry; 2002 Mar; 35(2):57-61. PubMed ID: 11951146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy of clonidine transdermal patch for treatment of Tourette's syndrome in children].
    Kang H; Zhang YF; Jiao FY; Guo XY; Gao XM
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):537-9. PubMed ID: 19650984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tics in Tourette syndrome: new treatment options.
    Awaad Y
    J Child Neurol; 1999 May; 14(5):316-9. PubMed ID: 10342599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Course of Tourette Syndrome and Comorbidities in a Large Prospective Clinical Study.
    Groth C; Mol Debes N; Rask CU; Lange T; Skov L
    J Am Acad Child Adolesc Psychiatry; 2017 Apr; 56(4):304-312. PubMed ID: 28335874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial.
    Gilbert DL; Sethuraman G; Sine L; Peters S; Sallee FR
    Neurology; 2000 Mar; 54(6):1310-5. PubMed ID: 10746603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome.
    Gaffney GR; Perry PJ; Lund BC; Bever-Stille KA; Arndt S; Kuperman S
    J Am Acad Child Adolesc Psychiatry; 2002 Mar; 41(3):330-6. PubMed ID: 11886028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic tics and Tourette syndrome in patients with obsessive-compulsive disorder.
    Diniz JB; Rosario-Campos MC; Hounie AG; Curi M; Shavitt RG; Lopes AC; Miguel EC
    J Psychiatr Res; 2006 Sep; 40(6):487-93. PubMed ID: 16289552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical effectiveness of quetiapine in children and adolescents with Tourette's syndrome : a retrospective case-note survey.
    Copur M; Arpaci B; Demir T; Narin H
    Clin Drug Investig; 2007; 27(2):123-30. PubMed ID: 17217317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sociodemographic/Clinical characteristics and risk factors associated with chronic tic disorders].
    Hesapçıoğlu ST; Tural MK; Kandil S
    Turk Psikiyatri Derg; 2013; 24(3):158-67. PubMed ID: 24049006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reliability and validity of the Yale Global Tic Severity Scale.
    Storch EA; Murphy TK; Geffken GR; Sajid M; Allen P; Roberti JW; Goodman WK
    Psychol Assess; 2005 Dec; 17(4):486-91. PubMed ID: 16393016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience.
    Chappell PB; Riddle MA; Scahill L; Lynch KA; Schultz R; Arnsten A; Leckman JF; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1140-6. PubMed ID: 7559307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deep Brain Stimulation of the Globus Pallidus Internus in Patients with Intractable Tourette Syndrome: A 1-year Follow-up Study.
    Zhang XH; Li JY; Zhang YQ; Li YJ
    Chin Med J (Engl); 2016 May; 129(9):1022-7. PubMed ID: 27098785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensory phenomena related to tics, obsessive-compulsive symptoms, and global functioning in Tourette syndrome.
    Kano Y; Matsuda N; Nonaka M; Fujio M; Kuwabara H; Kono T
    Compr Psychiatry; 2015 Oct; 62():141-6. PubMed ID: 26343478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double blind randomized placebo control trial of levetiracetam in Tourette syndrome.
    Smith-Hicks CL; Bridges DD; Paynter NP; Singer HS
    Mov Disord; 2007 Sep; 22(12):1764-70. PubMed ID: 17566124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tic disorders and arousal dysfunction: clinical evaluation of 49 children and adolescents].
    Romano A; Cundari G; Bruni O; Cardona F
    Minerva Pediatr; 2004 Jun; 56(3):327-34. PubMed ID: 15252381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and safety of risperidone for children and adolescents with chronic tic or tourette disorders in Korea.
    Kim BN; Lee CB; Hwang JW; Shin MS; Cho SC
    J Child Adolesc Psychopharmacol; 2005 Apr; 15(2):318-24. PubMed ID: 15910216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thinning of the motor-cingulate-insular cortices in siblings concordant for Tourette syndrome.
    Fahim C; Yoon U; Sandor P; Frey K; Evans AC
    Brain Topogr; 2009 Nov; 22(3):176-84. PubMed ID: 19779823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tourette syndrome in a longitudinal perspective. Clinical course of tics and comorbidities, coexisting psychopathologies, phenotypes and predictors.
    Groth C
    Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.